The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
The enhanced permeability retention effect: a new paradigm for drug targeting in infection
Abstract
Multidrug-resistant, Gram-negative infection is a major global determinant of morbidity, mortality and cost of care. The advent of nanomedicine has enabled tailored engineering of macromolecular constructs, permitting increasingly selective targeting, alteration of volume of distribution and activity/toxicity. Macromolecules tend to passively and preferentially accumulate at sites of enhanced vascular permeability and are then retained. This enhanced permeability and retention (EPR) effect, whilst recognized as a major breakthrough in anti-tumoral targeting, has not yet been fully exploited in infection. Shared pathophysiological pathways in both cancer and infection are evident and a number of novel nanomedicines have shown promise in selective, passive, size-mediated targeting to infection. This review describes the similarities and parallels in pathophysiological pathways at molecular, cellular and circulatory levels between inflammation/infection and cancer therapy, where use of this principle has been established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Machado, G.-B., Assis, M.-C., Leão, R. S., Saliba, A. M., da Silva, M. C. A., Suassuna, J. H. R., OLIVEIRA, A. V. D., & Plotkowski, M. C. (2010) · Shock · doi:10.1097/shk.0b013e3181b2b0f4 · Cited by 34
Imaging Experimental Intraabdominal Abscesses With 99mTc-PEG Liposomes and 99mTc-HYNIC IgG
Dams, E. T. M., Reijnen, M. M. P. J., Oyen, W. J. G., Boerman, O. C., Laverman, P., Storm, G., van der Meer, J. W. M., Corstens, F. H. M., & van Goor, H. (1999) · Annals of Surgery · doi:10.1097/00000658-199904000-00015 · Cited by 33
Maeda, H., Akaike, T., Sakata, Y., & Maruo, K. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7397-0_13 · Cited by 32
Imamura, T., Tanase, S., Hayashi, I., Potempa, J., Kozik, A., & Travis, J. W. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00490-4 · Cited by 32
Use of colistin in treating multi-resistant Gram-negative organisms in a specialised burns unit
Ganapathy, H., Pal, S. K., Teare, L., & Dziewulski, P. G. (2009) · Burns · doi:10.1016/j.burns.2009.07.010 · Cited by 32
Mittermayer, F., Pleiner, J., Schaller, G., Weltermann, A., Kapiotis, S., Jilma, B., & Wolzt, M. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01192.x · Cited by 32
Nanomedicine for intracellular therapy
Ranjan, A., Pothayee, N., Seleem, M. N., Boyle, S. M., Kasimanickam, R. K., Riffle, J. S., & Sriranganathan, N. (2012) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2012.02566.x · Cited by 30
Colistin past and future: A bibliographic analysis
Azzopardi, E., Ferguson, E. L., & Thomas, D. W. (2012) · Journal of Critical Care · doi:10.1016/j.jcrc.2012.04.008 · Cited by 30
Self-citationSubstrate Specificity of the Streptococcal Cysteine Protease
Nomizu, M., Pietrzyński, G., Kato, T., Lachance, P., Menard, R., & Ziomek, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106306200 · Cited by 30
Kinin Modulation of Conventional Outflow Facility in the Bovine Eye
Webb, J. G., Husain, S., Yates, P. W., & Crosson, C. E. (2006) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2006.22.310 · Cited by 28
Kinin receptor expression during Staphylococcus aureus infection
Bengtson, S. H., Phagoo, S. B., Norrby‐Teglund, A., Påhlman, L. I., Mörgelin, M., Zuraw, B. L., Leeb-Lundberg, L. M. F., & Herwald, H. (2006) · Blood · doi:10.1182/blood-2006-04-016444 · Cited by 27
Seguin, T., Buléon, M., Destrube, M., Ranera, M.-T., Couture, R., Girolami, J., & Tack, I. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.08.008 · Cited by 26
Wang, D., Kong, L., Wang, J., He, X., Li, X., & Xiao, Y. (2009) · PubMed · Cited by 26
Pérez, F., Hujer, A. M., Hulten, E. A., Fishbain, J. T., Hujer, K. M., Aron, D. C., Thweatt, K. S., Donskey, C. J., & Bonomo, R. A. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.05.007 · Cited by 25
Generation of plasma kinin by three types of protease isolated from Porphyromonas gingivalis 381
Hinode, D., Nagata, A., ICHIMIYA, S., et al. (1992) · Archives of Oral Biology · doi:10.1016/0003-9969(92)90120-w · Cited by 24
Beneficial Effects of a Bradykinin Antagonist in a Model of Gram-Negative Sepsis
Ridings, P. C., Blocher, C. R., Fisher, B. J., Fowler, A. A., & Sugerman, H. J. (1995) · doi:10.1097/00005373-199507000-00011 · Cited by 24
Imamura, T., Potempa, J., & Travis, J. W. (2000) · Microbial Pathogenesis · doi:10.1006/mpat.2000.0380 · Cited by 23
Alkaline protease-deficient mutants of Pseudomonas aeruginosa are virulent in the eye
Pillar, C. M., Hazlett, L. D., & Hobden, J. A. (2000) · Current Eye Research · doi:10.1076/0271-3683(200009)2131-rft730 · Cited by 23
Vascular permeability enhancing activity of Porphyromonas gingivalis protease in guinea pigs
Kaminishi, H., Cho, T., Itoh, T., Iwata, A., Kawasaki, K., Hagihara, Y., & Maeda, H. (1993) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1993.tb06559.x · Cited by 21
Effects of Bradykinin on Prostaglandin I2Synthesis in Human Vascular Endothelial Cells
Yamasaki, S., Sawada, S., Komatsu, S., Kawahara, T., Tsuda, Y., Sato, T., Toratani, A., Kono, Y., Higaki, T., Imamura, H., et al. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.201 · Cited by 20
DX‐9065a inhibits proinflammatory events induced by gingipains and factor Xa
Matsushita, K., Imamura, T., Tomikawa, M., Tancharoen, S., Tatsuyama, S., & Maruyama, I. (2006) · Journal of Periodontal Research · doi:10.1111/j.1600-0765.2005.00853.x · Cited by 19
Bradykinin does not induce gap formation between human endothelial cells
Jungmann, P. M., Wilhelmi, M., Oberleithner, H., & Riethmüller, C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0352-x · Cited by 17
Sikkink, C. J. J. M., Reijnen, M. M. P. J., Laverman, P., Oyen, W. J. G., & van Goor, H. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.07.018 · Cited by 15
Pathogenic Factors of Vibrios with Special Emphasis on Vibrio vulnificus
Shinoda, S. (2005) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.125.531 · Cited by 14
Experimental polymer storage disease in rabbits: An approach to the histogenesis of sphingolipidoses
Miyasaki, K. (1975) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00471182 · Cited by 13
Protein synthesis dependent effects of kinins on astrocyte prostaglandin synthesis
Filipovich‐Rimon, T., & Fleisher‐Berkovich, S. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.006 · Cited by 12
Pathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Pharmaceutical Nanocarriers in Treatment and Imaging of Infection
Schiffelers, R. M., Storm, G., & Bakker‐Woudenberg, I. A. J. M. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0029 · Cited by 4
Cited by
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Nichols, J. W., & Bae, Y. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.057 · Cited by 834
Burn injury: Challenges and advances in burn wound healing, infection, pain and scarring
Wang, Y., Beekman, J., Hew, J., Jackson, S., Issler-Fisher, A. C., Parungao, R., Lajevardi, S. S., Li, Z., & Maitz, P. K. M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.018 · Cited by 696
Stimuli-Responsive Nanomaterials for Biomedical Applications
Blum, A. P., Kammeyer, J. K., Rush, A. M., Callmann, C. E., Hahn, M. E., & Gianneschi, N. C. (2015) · Journal of the American Chemical Society · doi:10.1021/ja510147n · Cited by 540
Metadata
- Authors
- Azzopardi, E. A., Ferguson, E. L., & Thomas, D. W.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10-10
- Volume
- 68
- Issue
- 2
- Pages
- 257-274
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2148357124
- Cited by
- 312
- References
- 228
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.